POL6014
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for POL6014, covering 2021-09-28 to 2021-09-28. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of POL6014 in Patients With CF [Phase 1, Phase 2]